chr12-9998309-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016509.4(CLEC1B):c.136G>T(p.Val46Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000289 in 1,614,112 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016509.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CLEC1B | NM_016509.4 | c.136G>T | p.Val46Phe | missense_variant | 2/6 | ENST00000298527.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CLEC1B | ENST00000298527.11 | c.136G>T | p.Val46Phe | missense_variant | 2/6 | 1 | NM_016509.4 | P1 | |
CLEC1B | ENST00000348658.4 | c.64+728G>T | intron_variant | 1 | |||||
CLEC1B | ENST00000428126.6 | c.64+728G>T | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.000421 AC: 64AN: 152136Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000460 AC: 115AN: 249812Hom.: 0 AF XY: 0.000458 AC XY: 62AN XY: 135516
GnomAD4 exome AF: 0.000275 AC: 402AN: 1461858Hom.: 1 Cov.: 30 AF XY: 0.000276 AC XY: 201AN XY: 727230
GnomAD4 genome AF: 0.000420 AC: 64AN: 152254Hom.: 0 Cov.: 31 AF XY: 0.000403 AC XY: 30AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.136G>T (p.V46F) alteration is located in exon 2 (coding exon 2) of the CLEC1B gene. This alteration results from a G to T substitution at nucleotide position 136, causing the valine (V) at amino acid position 46 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at